IL-1 induces mitochondrial translocation of IRAK2 to suppress oxidative metabolism in adipocytes

Hao Zhou,Han Wang,Minjia Yu,Rebecca C. Schugar,Wen Qian,Fangqiang Tang,Weiwei Liu,Hui Yang,Ruth E. McDowell,Junjie Zhao,Ji Gao,Ashok Dongre,Julie A. Carman,Mei Yin,Judith A. Drazba,Robert Dent,Christopher Hine,Yeong-Renn Chen,Jonathan D. Smith,Paul L. Fox,J. Mark Brown,Xiaoxia Li

DOI: https://doi.org/10.1038/s41590-020-0750-1

IF: 30.5

2020-08-10

Nature Immunology

Abstract:Chronic inflammation is a common feature of obesity, with elevated cytokines such as interleukin-1 (IL-1) in the circulation and tissues. Here, we report an unconventional IL-1R–MyD88–IRAK2–PHB/OPA1 signaling axis that reprograms mitochondrial metabolism in adipocytes to exacerbate obesity. IL-1 induced recruitment of IRAK2 Myddosome to mitochondria outer membranes via recognition by TOM20, followed by TIMM50-guided translocation of IRAK2 into mitochondria inner membranes, to suppress oxidative phosphorylation and fatty acid oxidation, thereby attenuating energy expenditure. Adipocyte-specific MyD88 or IRAK2 deficiency reduced high-fat-diet-induced weight gain, increased energy expenditure and ameliorated insulin resistance, associated with a smaller adipocyte size and increased cristae formation. IRAK2 kinase inactivation also reduced high-fat diet-induced metabolic diseases. Mechanistically, IRAK2 suppressed respiratory super-complex formation via interaction with PHB1 and OPA1 upon stimulation of IL-1. Taken together, our results suggest that the IRAK2 Myddosome functions as a critical link between inflammation and metabolism, representing a novel therapeutic target for patients with obesity.

immunology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the pathological mechanisms of obesity and its related metabolic syndromes, especially focusing on the role of inflammatory signaling pathways in adipocytes. Specifically, the study aims to explore how Toll - like receptor (TLRs) and interleukin - 1 receptor (IL - 1R) signals affect the metabolic functions of adipocytes through MyD88 and IRAK2 molecules, thereby exacerbating obesity and related metabolic disorders. The study found that IL - 1β stimulation can induce IRAK2 to transfer from the cytoplasm to the mitochondria and interact with mitochondrial proteins (such as PHB and OPA1), inhibiting the formation of the mitochondrial respiratory chain super - complex, thereby reducing oxidative phosphorylation and fatty acid β - oxidation and decreasing energy consumption. Therefore, the main objective of the paper is to reveal the mechanism of action of the IL - 1R - MyD88 - IRAK2 signaling axis in obesity and metabolic syndromes, as well as the possibility of this signaling axis as a potential target for treating obesity.